Global Biologics Market to Surpass USD 612 Billion by 2030- States Markntel Advisors

The surging expenditures in healthcare, a hike in the sedentary lifestyle of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the biologics market growth globally. Moreover, the rising surge in the old age population is notably augmenting the demand for biologics such as erythropoietin, denosumab, teriparatide, etc.

Key Highlights of Report

·        Historical Years: 2020–2023​

·        Base Year: 2024​

·        Forecast Period: 2025–2030​

·        Leading Segment: Monoclonal Antibodies​

·        Leading Region: North America​

·        CAGR: 8.25%​

·        Market Size Projection: USD 612 billion by 2030​

Biologics Market Analytical Overview 2025-30

According to the latest report published by Markntel Advisors, the Global Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030. North America biologics market is held the largest shares owing to the sturdy healthcare infrastructure and great investments in biopharmaceutical studies. Furthermore, the market growth has also been influenced by the presence of a favorable regulatory environment, which fosters accelerated approvals for biologics.

Biologics Industry Segmentation Analysis 2025

The industry is further bifurcated into:

Based on Therapeutic Application:

·        Oncology,

·        Infectious Disease,

·        Autoimmune Disease,

·        Diabetes,

·        Cardiovascular Diseases,

·        Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)

Based on Drug Class:

·        Recombinant Proteins, [Hormones, Cytokines],

·        Monoclonal Antibodies,

·        Blood & Blood Components,

·        Cellular & Gene Therapy,

·        Vaccines, Others

Based on Source:

·        Microbes,

·        Humans,

·        Others (Rodents, Plants, etc.)

Based on Region:

·        North America

·        South America

·        Europe

·        The Middle East & Africa

·        Asia-Pacific

Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Biologics Market Trends 2025

·        Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases such as cancer, autoimmune disorders, and diabetes is driving the demand for biologic therapies.

·        Advancements in Biotechnology: Technological innovations are enhancing the development and production of biologics, leading to more effective treatments.

·        Growing Geriatric Population: An aging global population is contributing to a higher demand for biologic therapies to manage age-related diseases.

Leading Players in Biologics Market

Key companies operating in the global biologics market include:

·        Bristol-Myers Squibb,

·        Pfizer,

·        Sanofi,

·        Janssen Biotech, Inc.,

·        Bayer AG,

·        Merck & Co.,

·        Amgen Inc.,

·        Abbott GmbH,

·        Novartis,

·        AstraZeneca Plc,

·        GlaxoSmithKline Biologicals,

·        Moderna, Inc.,

·        Ferring Pharmaceuticals Inc.,

·        Aimmune Therapeutics, Inc.,

·        F. Hoffman La Roche, and Others

FAQs

Q: What is the projected growth rate of the global biologics market by 2030?

A: The market is expected to grow at a CAGR of approximately 8.25%, reaching USD 612 billion by 2030. ​

Q: Which segment holds the largest share in the biologics market?

A: The Monoclonal Antibodies segment holds the largest market share, driven by its efficacy in treating various diseases.

Q: What are the main factors driving the demand for biologics?

A: Key drivers include the rising prevalence of chronic diseases, advancements in biotechnology, and a growing geriatric population.

Q: Which regions are leading in the adoption of biologics?

A: North America leads in market adoption, attributed to advanced healthcare infrastructure and high awareness levels.

Q: Who are the major players in the global biologics market?

A: Major players include Amgen Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., and F. Hoffmann-La Roche Ltd., among others.

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

For Media Inquiries, Please Contact:

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India